Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Prostate Cancer

Free Subscription 01.07.2024 4 Anticancer Res 1 BMC Cancer 1 BMC Urol 1 Cancer Lett 1 Curr Treat Options Oncol 1 Eur J Radiol 2 Eur Radiol 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Nucl Med 1 J Urol 2 Lancet Oncol 1 Magn Reson Med 2 Prostate 1 Radiology 1 Semin Oncol 6 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Res

1. KUSTER JHS, Erb HHH, Ahrend H, Abazid A, et al
   Modulation of the Prostate Cancer Resistance Factor Hsp27 by the Chemotherapeutic Drugs Abiraterone, Cabazitaxel, Docetaxel and Enzalutamide.
   Anticancer Res. 2024;44:2815-2821.
   PubMed         Abstract available
   
   
2. MITSUNARI K, Fukushima H, Kurata H, Harada J, et al
   Predictive Factors for Early Biochemical Recurrence Following Robot-assisted Radical Prostatectomy: The Impact of PSA Level, Gleason Score, and Pathological Tumor Stage.
   Anticancer Res. 2024;44:3149-3154.
   PubMed         Abstract available
   
   
3. YAMAMOTO Y, Nishimoto M, Akashi Y, Kiba K, et al
   Impact of Novel Agents on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer.
   Anticancer Res. 2024;44:3155-3161.
   PubMed         Abstract available
   
   
4. HAN S, Jang S, Lee SW, Kim HY, et al
   hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3-Erk1/2 Signaling Pathway.
   Anticancer Res. 2024;44:2847-2859.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. HUANG J, Sun J, Wang K, Zheng L, et al
   Causal relationship between prostatic diseases and prostate cancer: a mendelian randomization study.
   BMC Cancer. 2024;24:774.
   PubMed         Abstract available
   
   

   
   BMC Urol

6. XIANG AP, Shen YF, Shen XF, Shao SH, et al
   Correlation between the incidence of inguinal hernia and risk factors after radical prostatic cancer surgery: a case control study.
   BMC Urol. 2024;24:131.
   PubMed         Abstract available
   
   

   
   Cancer Lett

7. CLARK A, Villarreal MR, Huang SB, Jayamohan S, et al
   Targeting S6K/NFkappaB/SQSTM1/Poltheta signaling to suppress radiation resistance in Prostate Cancer.
   Cancer Lett. 2024 Jun 24:217063. doi: 10.1016/j.canlet.2024.217063.
   PubMed         Abstract available
   
   

   
   Curr Treat Options Oncol

8. KULASEGARAN T, Oliveira N
   Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management.
   Curr Treat Options Oncol. 2024 Jun 24. doi: 10.1007/s11864-024-01215.
   PubMed         Abstract available
   
   

   
   Eur J Radiol

9. KLUCKERT J, Hotker AM, Da Mutten R, Konukoglu E, et al
   AI-based automated evaluation of image quality and protocol tailoring in patients undergoing MRI for suspected prostate cancer.
   Eur J Radiol. 2024;177:111581.
   PubMed         Abstract available
   
   

   
   Eur Radiol

10. STANZIONE A, Lee KL, Sanmugalingam N, Rajendran I, et al
    Expect the unexpected: investigating discordant prostate MRI and biopsy results.
    Eur Radiol. 2024;34:4810-4820.
    PubMed         Abstract available
    
    
11. LANGKILDE F, Masaba P, Edenbrandt L, Gren M, et al
    Manual prostate MRI segmentation by readers with different experience: a study of the learning progress.
    Eur Radiol. 2024;34:4801-4809.
    PubMed         Abstract available
    
    

    
    Int J Cancer

12. HUANG CY, Huang CP, Huang YY, Huang SK, et al
    Real-world safety and effectiveness of radium-223 in patients with metastatic castration-resistant prostate cancer: Interim analyses of the prospective, observational RAPIT study.
    Int J Cancer. 2024 Jun 26. doi: 10.1002/ijc.35040.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

13. ZHONG AY, Lui AJ, Kuznetsova S, Kallis K, et al
    Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost.
    Int J Radiat Oncol Biol Phys. 2024 Jun 24:S0360-3016(24)00740.
    PubMed         Abstract available
    
    

    
    J Nucl Med

14. BAUCKNEHT M, Lanfranchi F, Albano D, Triggiani L, et al
    Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study).
    J Nucl Med. 2024 Jun 27:jnumed.124.267586. doi: 10.2967/jnumed.124.267586.
    PubMed         Abstract available
    
    

    
    J Urol

15. NANDALUR KR, Shen C, Zhao L, Al-Katib S, et al
    Association of Baseline MRI PI-RADS Score With Prostate Cancer Active Surveillance Early Biopsy Reclassification: Data From the Michigan Urological Surgery Improvement Collaborative (MUSIC).
    J Urol. 2024 Jun 25:101097JU0000000000004117. doi: 10.1097/JU.0000000000004117.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

16. EKLUND M
    Artificial intelligence for scoring prostate MRI: ready for prospective evaluation.
    Lancet Oncol. 2024;25:827-828.
    PubMed        
    
    
17. HUANG J, Leng F
    Dual therapy in metastatic castration-resistant prostate cancer.
    Lancet Oncol. 2024;25:e283.
    PubMed        
    
    

    
    Magn Reson Med

18. WANG Z, Luo G, Li Y, Cao P, et al
    Using a deep learning prior for accelerating hyperpolarized (13)C MRSI on synthetic cancer datasets.
    Magn Reson Med. 2024;92:945-955.
    PubMed         Abstract available
    
    

    
    Prostate

19. MASSANOVA M, Barone B, Caputo VF, Napolitano L, et al
    The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy-naive patients, according to the localization of the lesion at the mpMRI: A single-center retrospective observational study.
    Prostate. 2024 Jun 25. doi: 10.1002/pros.24761.
    PubMed         Abstract available
    
    
20. KAYAR R, Tokuc E, Ozsoy E, Demir S, et al
    The predictive impact of hematological inflammatory markers in detecting prostate cancer in patients with PI-RADS 3 lesions on multiparametric magnetic resonance imaging.
    Prostate. 2024 Jun 26. doi: 10.1002/pros.24762.
    PubMed         Abstract available
    
    

    
    Radiology

21. JEWELL K, Hofman MS, Ong JSL, Levy S, et al
    Erratum for: Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy.
    Radiology. 2024;311:e249017.
    PubMed        
    
    

    
    Semin Oncol

22. LEUVA H, Moran G, Jamaleddine N, Meseha M, et al
    Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer.
    Semin Oncol. 2024 May 11:S0093-7754(24)00037.
    PubMed         Abstract available
    
    

    
    Urology

23. BOLOGNA E, Autorino R
    Reply to Editorial Comment on "Incidence and Management of Radiation Cystitis After Pelvic Radiotherapy for Prostate Cancer: Analysis from a National Database".
    Urology. 2024 Jun 20:S0090-4295(24)00475-8. doi: 10.1016/j.urology.2024.
    PubMed        
    
    
24. SANTORO G, Lombardo R, De Nunzio C
    Letter to the Editor on "Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy".
    Urology. 2024 Jun 20:S0090-4295(24)00480-1. doi: 10.1016/j.urology.2024.
    PubMed        
    
    
25. RAMOS-CARPINTEYRO R, Kaouk J
    Reply to Letter to the Editor on "Predictors of Early Continence After Single-port Transvesical Robot-assisted Radical Prostatectomy".
    Urology. 2024;188:169.
    PubMed        
    
    
26. FRANCO A, Guercio A, Lombardo R, De Nunzio C, et al
    Letter to the Editor on "Predictors of Early Continence after Single-Port Transvesical Robot-Assisted Radical Prostatectomy".
    Urology. 2024;188:167-168.
    PubMed        
    
    
27. GHAMANDE SS, Cline JK, Sayyid RK, Klaassen Z, et al
    Advancing Precision Oncology With Artificial Intelligence: Ushering in the ArteraAI Prostate Test.
    Urology. 2024;188:20-23.
    PubMed        
    
    
28. TRINER D, Johnson K, Meah S, Daignault-Newton S, et al
    RECOVERY OF SOCIAL CONTINENCE AND SEXUAL FUNCTION IN MEN WITH HIGH-RISK PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: RESULTS FROM A STATEWIDE COLLABORATIVE.
    Urology. 2024 Jun 25:S0090-4295(24)00464-3. doi: 10.1016/j.urology.2024.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.